These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23114136)

  • 21. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
    Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
    Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
    Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
    Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decitabine in myelodysplastic syndromes.
    Saba HI; Wijermans PW
    Semin Hematol; 2005 Jul; 42(3 Suppl 2):S23-31. PubMed ID: 16015501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine.
    Gao R; Ma D; Wang P; Sun J; Wang JS; Fang Q
    Genet Mol Res; 2015 Dec; 14(4):17788-98. PubMed ID: 26782424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation changes following 5-azacitidine treatment in patients with myelodysplastic syndrome.
    Tran HT; Kim HN; Lee IK; Kim YK; Ahn JS; Yang DH; Lee JJ; Kim HJ
    J Korean Med Sci; 2011 Feb; 26(2):207-13. PubMed ID: 21286011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.
    Leone G; Teofili L; Voso MT; Lübbert M
    Haematologica; 2002 Dec; 87(12):1324-41. PubMed ID: 12495905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine.
    Borthakur G; Ahdab SE; Ravandi F; Faderl S; Ferrajoli A; Newman B; Issa JP; Kantarjian H
    Leuk Lymphoma; 2008 Apr; 49(4):690-5. PubMed ID: 18398735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
    Wang JX; Zhang YG; Zhao LS
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.
    Mund C; Hackanson B; Stresemann C; Lübbert M; Lyko F
    Cancer Res; 2005 Aug; 65(16):7086-90. PubMed ID: 16103056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma].
    Yin D; Dong M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):253-5, 258. PubMed ID: 16013507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FHIT expression and hypermethylation in esophageal squamous cell carcinoma.
    Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W
    Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome.
    Wu L; Shi W; Li X; Chang C; Xu F; He Q; Wu D; Su J; Zhou L; Song L; Xiao C; Zhang Z
    J Transl Med; 2016 Mar; 14():66. PubMed ID: 26944860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.
    Ma D; Fang Q; Wang P; Gao R; Sun J; Li Y; Hu XY; Wang JS
    Gene Ther; 2015 Apr; 22(4):287-96. PubMed ID: 25652099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
    Harel S; Cherait A; Berthon C; Willekens C; Park S; Rigal M; Brechignac S; Thépot S; Quesnel B; Gardin C; Adès L; Fenaux P; Braun T
    Leuk Res; 2015 May; 39(5):501-4. PubMed ID: 25735917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The euphoria of hypomethylating agents in MDS and AML: is it justified?
    Sekeres MA
    Best Pract Res Clin Haematol; 2013 Sep; 26(3):275-8. PubMed ID: 24309530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis.
    Zhao Y; Fei C; Zhang X; Zhang Y; Guo J; Gu S; Li X; Chang C
    Tumour Biol; 2013 Feb; 34(1):165-72. PubMed ID: 23055192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
    Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
    Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methylation status of FHIT gene in plasma and expression of FHIT gene in cancer tissue of cervical cancer patients].
    Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):565-7. PubMed ID: 17029211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
    Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.